# OnCo record nct06618235 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06618235/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06618235", "NCT06618235" ;
  schema:name "Trial of THEO-260 in Ovarian Cancer Patients"@en ;
  schema:alternateName "OCTOPOD"@en ;
  schema:description "A phase 1/2 trial of THEO-260 in ovarian cancer, run by Theolytics Limited, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06618235/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06618235> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2024-09-24" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/high-grade-serous-ovarian-cancer/> ;
  onco:drugs <https://onco.cc/drugs/theo-260/> ;
  onco:companies <https://onco.cc/companies/theolytics/> .